FR2273554A1 - Derives de prostaglandines et medicaments contenant ces substances - Google Patents

Derives de prostaglandines et medicaments contenant ces substances

Info

Publication number
FR2273554A1
FR2273554A1 FR7517238A FR7517238A FR2273554A1 FR 2273554 A1 FR2273554 A1 FR 2273554A1 FR 7517238 A FR7517238 A FR 7517238A FR 7517238 A FR7517238 A FR 7517238A FR 2273554 A1 FR2273554 A1 FR 2273554A1
Authority
FR
France
Prior art keywords
substances
products containing
medicinal products
prostaglandin derivatives
prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7517238A
Other languages
English (en)
French (fr)
Other versions
FR2273554B1 (en:Method
Inventor
Samuel Wilkinson
Roderick John Flower
Sergio Henrique Ferreira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB24660/74A external-priority patent/GB1516642A/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2273554A1 publication Critical patent/FR2273554A1/fr
Application granted granted Critical
Publication of FR2273554B1 publication Critical patent/FR2273554B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F11/00—Compounds of calcium, strontium, or barium
    • C01F11/46—Sulfates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Geology (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7517238A 1974-06-04 1975-06-03 Derives de prostaglandines et medicaments contenant ces substances Granted FR2273554A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB24660/74A GB1516642A (en) 1974-06-04 1974-06-04 Biological reagent
GB5398674 1974-12-13

Publications (2)

Publication Number Publication Date
FR2273554A1 true FR2273554A1 (fr) 1976-01-02
FR2273554B1 FR2273554B1 (en:Method) 1978-07-28

Family

ID=26257224

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7517238A Granted FR2273554A1 (fr) 1974-06-04 1975-06-03 Derives de prostaglandines et medicaments contenant ces substances

Country Status (12)

Country Link
US (1) US4110432A (en:Method)
JP (1) JPS519714A (en:Method)
AU (1) AU8180175A (en:Method)
CH (1) CH614221A5 (en:Method)
DE (1) DE2524637A1 (en:Method)
DK (1) DK248775A (en:Method)
ES (1) ES438163A1 (en:Method)
FI (1) FI751633A7 (en:Method)
FR (1) FR2273554A1 (en:Method)
IL (1) IL47412A0 (en:Method)
NL (1) NL7506560A (en:Method)
SE (1) SE7506313L (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0172962A1 (en) * 1984-08-30 1986-03-05 Ono Pharmaceutical Co., Ltd. Prostaglandins

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678671A (en) * 1981-12-15 1987-07-07 Cordis Europa N.V. Conjugates of anticoagulant and protein
NL188622C (nl) * 1981-12-15 1992-08-17 Cordis Europ Werkwijze ter verbetering van de bloedcompatibiliteit van een materiaaloppervlak door bekleding daarvan met een heparine of heparine-analoga en een eiwit houdende film, alsmede voorwerp, omvattende een oppervlak met verbeterde bloedcompatibiliteit verkregen onder toepassing van een op het oppervlak aangebrachte heparine of heparine-analoga en een eiwit houdende film.
US4749570A (en) * 1981-12-31 1988-06-07 The Governors Of The University Of Alberta Targeting conjugates of albumin and therapeutic agents
US4663160A (en) * 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
DE68919366T2 (de) * 1988-09-30 1995-05-18 Neorx Corp Spaltbare linker zur reduzierung der akkumulierung von immunokonjugaten in nicht-zielorganen.
US5171563A (en) * 1988-09-30 1992-12-15 Neorx Corporation Cleavable linkers for the reduction of non-target organ retention of immunoconjugates
US6007817A (en) 1988-10-11 1999-12-28 University Of Southern California Vasopermeability enhancing immunoconjugates
EP0540670B1 (en) * 1990-07-26 1996-03-20 Monsanto Company Method for preparation of crosslinked polyamines
US8333996B2 (en) * 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
US8728536B2 (en) * 1996-10-16 2014-05-20 Etex Corporation Chemotherapeutic composition using nanocrystalline calcium phosphate paste
EP3254710B1 (en) * 2003-04-11 2019-05-22 Etex Corporation Osteoinductive bone material
KR101218454B1 (ko) * 2004-04-15 2013-01-04 에텍스 코포레이션 세팅 지연 칼슘 포스페이트 페이스트
US8147860B2 (en) 2005-12-06 2012-04-03 Etex Corporation Porous calcium phosphate bone material

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3690834A (en) * 1971-01-11 1972-09-12 Syva Co Ligand determination with spin labeled compounds by receptor displacement
US3935074A (en) * 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0172962A1 (en) * 1984-08-30 1986-03-05 Ono Pharmaceutical Co., Ltd. Prostaglandins

Also Published As

Publication number Publication date
NL7506560A (nl) 1975-12-08
US4110432A (en) 1978-08-29
FI751633A7 (en:Method) 1975-12-05
SE7506313L (sv) 1975-12-05
DE2524637A1 (de) 1976-01-02
DK248775A (da) 1975-12-05
IL47412A0 (en) 1975-08-31
CH614221A5 (en:Method) 1979-11-15
FR2273554B1 (en:Method) 1978-07-28
ES438163A1 (es) 1977-05-16
AU8180175A (en) 1976-12-09
JPS519714A (en:Method) 1976-01-26

Similar Documents

Publication Publication Date Title
SE428426B (sv) Anordning for inandning av lekemedel i pulverform
FR2279406A1 (fr) Nouveaux derives de quinazoline et medicament les contenant
FR2282892A1 (fr) Derives de la purine et medicaments qui en contiennent
BE804558A (fr) Nouveaux derives de 2-amino- ou 4-amino-quinazoline et medicaments les contenant
FR2273554A1 (fr) Derives de prostaglandines et medicaments contenant ces substances
FR2293198A1 (fr) Medicament contenant un derive de s-dioxyde de thioxanthone
BE746656A (fr) 5-pyridyl-2-imidazolones et medicaments contenant ces composes
FR2289204A1 (fr) Nouveaux peptides et medicament contenant ces substances
FR2280380A1 (fr) Derives du benzimidazole et medicaments qui en contiennent
FR2312253A1 (fr) Derives de la piperazine et medicament contenant ces substances
FR2322593A1 (fr) Nouveaux analogues de prostaglandines et medicament les contenant
FR2318622A1 (fr) Derives de substitution du sulfure de diphenyle et medicament contenant ces substances
BE758050A (fr) Derives 5-nitro-furyliques et medicaments contenant de tels composes
FR2287224A1 (fr) Derives de la pyridine et medicaments qui en contiennent
BE802996R (fr) Nouveaux derives de la 4-amino-quinazolines, leur preparation et medicaments contenant ces derives
FR2289184A1 (fr) Medicament contenant un derive de carboxy-thioxanthone
FR2342971A1 (fr) Derives de la purine et medicament contenant ces substances
BE836225R (fr) Acides 3-(4-biphenyl)alcanoiques et medicaments contenant ces composes
FR2342973A1 (fr) Azapurines et medicaments contenant ces substances
FR2335228A1 (fr) Derives de la 5-fluoro-pyrimidine-4-one et medicament contenant ces substances
FR2281766A1 (fr) Oestratetraenes et medicament contenant ces substances
BE797623A (fr) Anilino-benzothiazoles leur preparation et medicament contenant ces subtances
FR2280374A1 (fr) Derives de la phenylbutazone et medicament contenant ces substances
FR2279418A1 (fr) Polypeptides utilisables comme contraceptifs et medicament contenant ces substances
BE781299A (fr) Derives de la 1(2h)-phtalazinone et medicaments en contenant

Legal Events

Date Code Title Description
ST Notification of lapse